NCT01733823已完成1 期
Phase I/II Study on Accelerated, Hyperfractionated Radiotherapy With Concomitant Cisplatin and Nimorazole for Patients With Stage III-IV p16 Negative Squamous Cell Cancer (SCC) of the Larynx, Pharynx and Oral Cavity
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 31
- 试验地点
- 8
- 主要终点
- Compliance
研究概览
简要总结
P16 negative cancers continue to have a dismal prognosis despite advances in the treatment of head and neck cancer. Acceleration, dose-escalation, hyperfractionation, chemotherapy and nimorazole has been shown to improve local control. The purpose of the study i to investigate the level of co-morbidity and performance status (PS) that allows the combination of all of the above means of treatment intensification
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Squamous Cell Carcinoma head and neck cancer of the pharynx, larynx and oral cavity
- •P16 negative
- •Organ function and performance status allowing radical chemo-radiotherapy
排除标准
- 未提供
结局指标
主要结局
Compliance
时间窗: End of radiotherapy (approximately 5.5 weeks after start of radiotherapy)
Proportion of patients that receive radiotherapy in accordance to prescribed dose and treatment time
次要结局
- Acute toxicity(2 months after end of radiotherapy)
- Response rate(2 months after end of radiotherapy)
研究者
研究点 (8)
Loading locations...
相似试验
已完成
1 期
PM14 Administered Intravenously to Patients With Advanced Solid TumorsNCT05076396PharmaMar126
已完成
1 期
Trial of SBRT With Concurrent Ipilimumab in Metastatic MelanomaEffects of ImmunotherapyAdverse Effect of Radiation TherapyMelanomaNCT02406183Radiotherapie13
Unknown
2 期
A Phase II Study of Conversion Surgery After IP Paclitaxel With XELOX Chemotherapy in AGC With Peritoneal DisseminationAdvanced Gastric CancerPeritoneal CarcinomatosisNCT04797923Gangnam Severance Hospital43
终止
2 期
Antineoplaston Therapy in Treating Patients With Advanced Head and Neck CancerHead and Neck CancerNCT00003489Burzynski Research Institute7
已完成
1 期
Dose-Escalated Hypofractionated Adaptive Radiotherapy for Head and Neck CancerHead and Neck NeoplasmNCT04477759Medical College of Wisconsin18